African leaders to attend 2022 World Economic Forum in Davos – CGTN

FILE PHOTO: A man silhouettes in front of the logo of the World Economic Forum in Davos, Switzerland, Sunday, Jan. 19, 2020. (Photo/Markus Schreiber,file)

FILE PHOTO: A man silhouettes in front of the logo of the World Economic Forum in Davos, Switzerland, Sunday, Jan. 19, 2020. (Photo/Markus Schreiber,file)

African presidents are expected join the world’s political and business elite in Davos, Switzerland, for the World Economic Forum’s Annual Meeting that starts today and is expected to run until May 26.The 2022 meeting is the first in-person meeting since the start of the COVID-19 pandemic.Happening under the theme of History at a Turning Point: Government Policies and Business Strategies, the meeting will have 200 sessions attended by more than 2,500 leaders and experts.Some of the African leaders that have confirmed attendance include Malawi President Lazarus Chakwera, Zimbabwe President Emmerson Mnangagwa, Namibia President Hage Geingob and Rwanda President Paul Kagame.The Forum is expected to place focus on the ongoing conflict in Ukraine.The 2022 forum will also have panels on a host of other issues, including climate change, rising energy prices, global supply chain problems, gender inequality and poverty.

Family death from nursing shortage inspires African-native to earn Miami degree – Journal-News

It was a family tragedy that first led her to consider nursing as a career.A relative in her native African country died while in an under-staffed hospital, Addae said, with only one nurse for every 50 patients.“I vowed to become a nurse to care for the sick,” said Addae, a devout Christian. “I am a woman of faith.”Earning a degree while raising four young children requires much, she said. So, she often turns to one of her favorite Bible passages.“I can do all things through Christ who strengthens me. When the going gets tough, I just talk to my God.”Addae’s perseverance of handling both motherhood times four and undergraduate classes drew both the attention of and praise of Miami University Hamilton professors.“I remember bawling my eyes out one day when I was having a conversation with Miami Professor Dr. Eyad Mussallem because I thought I was going to fail a course,” Addae said. “He encouraged and believed in me when I felt I couldn’t find the strength to carry on.”Addae “is an excellent student who is always willing to volunteer to help other students and goes above and beyond what is asked of her in the classroom,” said Tricia Neu, assistant professor of Nursing and director of the FNP track. “We are so excited to have her in our grad program.”Addae wasn’t surprised by the academic assistance or high quality of it regional nursing professors.“I decided to enroll at Miami University Regionals because of its outstanding academic reputation.”And now she is also setting her sights on smashing a gender stereotype held by some family members in her old country.“Becoming a nurse practitioner will allow me to become the first woman among my siblings to pursue (an advanced degree),” she said. “I’ll break the stereotype that only men can achieve higher academic success in my family.”

Tunisia is sliding back into authoritarianism. Here’s what the US should do.

Nine long months have passed since the start of the slow-motion coup in Tunisia, a country that, until recently, offered one of the best hopes for democratization in the Middle East. After shuttering the parliament with tanks in July, President Kais Saied has suspended the constitution and dissolved the Supreme Judicial Council. In perhaps the most disturbing…

Harvard Creates Fund to Redress Its Ties to Slavery

Harvard University is committing $100 million to study and redress its ties to slavery, the university’s president announced Tuesday, and with that money will create an endowed “Legacy of Slavery Fund,” which will continue researching and memorializing that history, working with descendants of Black and Native American people enslaved at Harvard, as well as their…

Widespread population immunity of Covid-19 observed in South Africa before Omicron wave

1. Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng province, South Africa, before the omicron wave.
2. Epidemiologic data demonstrated a decoupling of hospitalizations and deaths from infections while omicron was circulating.
Evidence Rating Level: 2 (Good)
Study Rundown: The Omicron variant was first identified in November 2021 in Gauteng province, South Africa, and was designated as a variant of concern due to its predicted high transmissibility and its potential to evade immunity from neutralizing antibodies induced by vaccination or natural infection with wild-type virus. The omicron variant outcompeted the delta variant in Gauteng and was responsible for 98.4% of the cases sequenced in South Africa in December 2021, and a prior population-wide seroepidemiologic study demonstrate that 19.1% of the population was seropositive for Covid-19. However, there is a gap in knowledge as to understanding the seroprevalence of Covid-19 before the omicron wave. This study found that there was widespread underlying SARS-CoV-2 seropositivity in Gauteng before the omicron-dominant wave of Covid-19. This study was limited by changes in the frequency of testing over time which limited head-to-head comparisons of case numbers across waves, and the fourth omicron wave had not fully subsided at the time of this analysis, which will result in a lag in the reporting of data such as hospitalizations and deaths attributable to this wave. Nevertheless, these study’s findings are significant, as they demonstrate that there was widespread seropositivity of Covid-19 in Gauteng prior to the omicron wave and that there was a decoupling of hospitalizations and deaths from infections while omicron was circulating.
Click to read the study in NEJM
Relevant Reading: Omicron — Decoupling Infection from Severe Disease
In-Depth [seroepidemiologic survey]: This seroepidemiologic survey was conducted from October to December 2021 in Gauteng province, South Africa, to determine the seroprevalence of SARS-CoV-2 IgG, obtaining samples from 7010 participants, of whom 18.8% had received a Covid-19 vaccine. Patients who live in the Gauteng province and were able to provide written informed consent were eligible for the study. Patients who resided outside of the studied province or declined to participate were excluded from the study. The primary outcome measured was seroprevalence measured with dried-blood-spot samples and tested for IgG against SARS-CoV-2 spike protein and nucleocapsid protein. Outcomes in the primary analysis were assessed via unadjusted, univariable analyses for each risk factor with generalized linear models with a log link to estimate risk ratios. Based on the analysis, the seroprevalence of SARS-CoV-2 IgG ranged from 56.2% among children younger than 12 years (95% Confidence Interval [CI], 52.6 to 59.7) to 79.7% among adults older than 50 years of age (95% CI, 77.6 to 81.5). 93.1% of vaccinated participants were seropositive for SARS-CoV-2 while 68.4% of unvaccinated participants were seropositive. Epidemiologic data also demonstrated that the incidence of Covid-19 infection increased and subsequently decreased more rapidly during the omicron wave than it had during the three previous waves. The incidence of infection was decoupled from the incidences of hospitalization, recorded death, and excess death during the fourth wave, as compared to the proportions seen in the previous three waves. Overall, this study demonstrated that there was widespread Covid-19 seropositivity in the Gauteng province of South Africa before the omicron wave, showing that there was a decoupling of hospitalizations and deaths from Covid-19 infections while the omicron variant was still circulating.
Image: PD
©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.